Dergiler / Jinekoloji ve Obstetrik Derg. / 2005 / Cilt: 19 - Sayı: 4

Üremeye yardımcı tekniklerde gonadotropin serbestleştirici hormon analogları

Sayfa
196–200
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
🔖

Bu Makaleye Atıf Yap

ÇEPNİ, İ. (2022). Üremeye yardımcı tekniklerde gonadotropin serbestleştirici hormon analogları. Jinekoloji ve Obstetrik Derg., Cilt: 19 - Sayı: 4, 196–200. https://ajindex.com/articles/559054

Kaynakça (1)

  1. Hodgen GD: The dominant ovarian follicle. Fertil Steril 38(3):281-300, 1982. 2.Lavy G, Pellicer A, Diamond MP, DeCherney AH: Ovarian stimulation for in vitro fertilization and embryo transfer, human menopausal gonadotropin versus pure human follicle stimulating hormone: a randomized prospective study. Fertil Steril 50(1):74-8, 1988. 3.Lamb EJ, Colliflower WW, Williams JW: Endometrial histo­logy and conception rates after clomiphene citrate. Obstet Gyne­col 39(3):389-96, 1972. 4.Lopata A, Brown JB, Leeton JF, Talbot JM, Wood C: In vit­ro fertilization of preovulatory oocytes and embryo transfer in in­fertile patients treated with clomiphene and human chorionic go-nadotropin.fertil Steril 30(1):27-35, I978. 5.Messinis IE, Templeton AA: Endocrine and follicle characte­ristics of cycles with and without endogenous luteinizing hormo­ne surges during superovulation induction with pulsatile follicle-stimulating hormone. Hum Reprod 2(1): 11 -6, 1987. 6.Fleming R, Coutts JR: LHRH analogues can be luteotrophic. Clin Endocrinol (Oxf) 17(6):593-9, 1982. 7.Wildt L, Diedrich K, van der Ven H, al Hasani S, Hubner H, Klasen R: Ovarian hyperstimulation for in-vitro fertilization controlled by GnRH agonist administered in combination with hu­man menopausal gonadotrophins. Hum Reprod 1(1): 15-9, 1986. 8.Macnamee MC, Howies CM, Edwards RG: Pregnancies af­ter IVF when high tonic LH is reduced by long-term treatment with GnRH agonists. Hum Reprod 2(7):569-71, 1987. 9.Salat-Baroux J, Antoine JM, Alvarez S, Cornet D, Tibi C, Mandelbaum J, Plachot M: Programmed ovulation induction and oocyte retrieval for in vitro fertilization. J In Vitro Fert Embr­yo Transf 5(3): 153-7, 1988. 10.Neveu S, Hedon B, Bringer J, Chinchole JM, Arnal F, Hu-meau C, Cristol P, Viala JL: Ovarian stimulation by a combina­tion of a gonadotropin-releasing hormone agonist and gonadotro­pins for in vitro fertilization. Fertil Steril 47(4):639-43, 1987. 11.Diedrich K, Diedrich C, Santos E, Zoll C, al-Hasani S, Re-issmann T, Krebs D, KlingmuUer D: Suppression of the endoge­nous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.Hum Reprod 9(5):788-91, 1994. 12.Olivennes F, Fanchin R, Bouchard P, de Ziegler D, Taieb J, Selva J, Frydman R: The single or dual administration of the gonadotropin-releasing hormone antagonist Cetrorelix in an in vit­ro fertilization-embryo transfer program. Fertil Steril 62(3):468-76, 1994. 13.Itskovitz-Eldor J, Kol S, Ma